Simplex Trading’s Aegerion Pharmaceuticals AEGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-93
Closed -$21K 7121
2016
Q3
$21K Sell
93
-121
-57% -$210 ﹤0.01% 2945
2016
Q2
$48K Buy
214
+157
+275% +$359 ﹤0.01% 2113
2016
Q1
$34K Sell
57
-186
-77% -$1.15K ﹤0.01% 2328
2015
Q4
$88K Buy
243
+142
+141% +$1.71K 0.01% 1464
2015
Q3
$55K Buy
101
+97
+2,425% +$1.73K ﹤0.01% 1923
2015
Q2
$7K Sell
4
-8
-67% -$173 ﹤0.01% 3451
2015
Q1
$3K Sell
12
-136
-92% -$3.46K ﹤0.01% 3986
2014
Q4
$191K Buy
+148
New +$3.73K 0.02% 626

Simplex Trading's AEGR Position: Q4 2016 in Review

Simplex Trading sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 6,820 shares — an estimated $20K sold.

Simplex Trading first reported a position in AEGR in Q4 2014 and held it in 6 quarters. The position peaked at $308K in Q4 2014. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

  • Simplex Trading reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Simplex Trading sold 6,820 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $20K.
  • Simplex Trading first reported a position in Aegerion Pharmaceuticals in Q4 2014 and held it in 6 quarters.
  • Simplex Trading's Aegerion Pharmaceuticals position peaked at $308K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Simplex Trading's 13F filing for Q4 2016, filed 11 Jan 2017.